Management of Typhoid Fever

First-Line Treatment Recommendation

• Azithromycin is the preferred first-line treatment for typhoid fever, particularly in areas with high fluoroquinolone resistance, at a dose of 500 mg once daily for 7 days in adults or 20 mg/kg/day (maximum 1g/day) for 7 days in children 1, 2, 3

Treatment Algorithm Based on Resistance Patterns

• Start with azithromycin as empiric therapy, especially for cases originating from South Asia where fluoroquinolone resistance exceeds 70% 1, 2
• Azithromycin demonstrates superior outcomes with lower risk of clinical failure (OR 0.48) and shorter hospital stays compared to fluoroquinolones 1, 3
• Risk of relapse is significantly lower with azithromycin (OR 0.09) compared to ceftriaxone 1, 3
• Fluoroquinolones (ciprofloxacin or ofloxacin) remain effective when susceptibility is confirmed 1, 3
• However, avoid empiric ciprofloxacin use for cases from South Asia due to resistance rates approaching 96% in some regions 4, 3

Specific Dosing Guidelines

• Azithromycin: 500 mg once daily for 7-14 days in adults 1, 3
• Azithromycin: 20 mg/kg/day (maximum 1g/day) for 7 days in children 1, 2
• Ceftriaxone: 1-2g IV/IM daily for 5-7 days in adults 1
• Ceftriaxone: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days in children 1, 2

Critical Diagnostic Considerations

• Obtain blood cultures before starting antibiotics whenever possible, as they have the highest yield within the first week of symptom onset 1, 3
• For patients with sepsis features, start broad-spectrum antimicrobial therapy immediately after collecting blood cultures 2, 3

Monitoring and Expected Response

• Expect fever clearance within 4-5 days of appropriate therapy 1, 3
• Monitor for clinical improvement; if no response by day 5, consider resistance or alternative diagnosis 1
• Complete the full 7-day course to prevent relapse, which occurs in 10-15% of inadequately treated cases 1

Management of Complications

• Intestinal perforation occurs in 10-15% of patients with illness duration exceeding 2 weeks 1
• Surgical intervention with simple excision and closure is required for perforation, reported successful in up to 88.2% of cases 1

Common Pitfalls to Avoid

• Never use ciprofloxacin empirically for cases from South or Southeast Asia due to widespread resistance 4, 3
• Do not discontinue antibiotics prematurely; complete the full course even if fever resolves early 1
• Avoid combination typhoid-paratyphoid vaccines; only monovalent S. typhi preparations should be used 5

Adverse Effects and Drug Interactions

• Common azithromycin adverse effects include gastrointestinal symptoms: nausea, vomiting, abdominal pain, and diarrhea 1, 3
• Monitor for potential drug interactions with azithromycin, particularly QT-prolonging medications 1

Prevention Strategies

• Typhoid vaccination is recommended for travelers to endemic areas, particularly Latin America, Asia, and Africa 5, 1
• Vaccination provides incomplete protection (does not protect against paratyphoid) and should not replace food and water safety precautions 5, 1, 3
• Hand hygiene and appropriate food safety practices remain essential 1

Emerging Resistance Concerns

• Always consider local resistance patterns when selecting empiric therapy, as these vary geographically and change over time 2

Azithromycin vs Cefixime for Typhoid Fever

Evidence Supporting Azithromycin

• Azithromycin demonstrates significantly lower risk of clinical failure (OR 0.48, 95% CI 0.26-0.89) compared to fluoroquinolones, and cefixime performs worse than fluoroquinolones in head-to-head trials, according to the Clinical Microbiology and Infection journal 6, 7
• Azithromycin reduces hospital stay by approximately 1 day compared to fluoroquinolones (MD -1.04 days, 95% CI -1.73 to -0.34 days), as reported in the Clinical Microbiology and Infection journal 6, 7
• Azithromycin shows dramatically lower relapse rates (OR 0.09, 95% CI 0.01-0.70) compared to ceftriaxone, while cefixime has documented relapse rates of 4-37.6%, according to the Journal of Infection 8
• Cefixime has reported treatment failure rates of 4-37.6% in clinical practice, as documented in the Journal of Infection 8
• The World Health Organization lists cefixime only as an "alternative" option, not first-line, and recommends azithromycin as a preferred treatment, as supported by the Clinical Microbiology and Infection journal 7
• If cefixime must be used, a mandatory test-of-cure at 1 week is required due to high failure rates, as recommended by the Morbidity and Mortality Weekly Report 9
• Over 70% of S. typhi isolates from South Asia are fluoroquinolone-resistant, making azithromycin a critical treatment option, according to the Journal of Infection 8

Typhoid Fever Treatment and Prevention

Vaccination

• The Centers for Disease Control and Prevention recommends Ty21a oral vaccine for travelers to endemic areas, with a dosing regimen of one enteric-coated capsule taken on alternate days for a total of four capsules, for adults and children ≥10 years 10, 11, 12
• The Ty21a oral vaccine should be taken with cool liquid no warmer than 37°C, approximately 1 hour before a meal, and capsules must be kept refrigerated, with all four doses required to achieve maximum efficacy 10, 11, 12
• Booster doses for Ty21a oral vaccine should be repeated every 5 years 11
• The parenteral inactivated vaccine is administered as 0.5 ml subcutaneously, given on two occasions separated by ≥4 weeks, for adults and children ≥10 years, with a booster dose every 3 years under conditions of continued exposure 10, 11, 12

Prevention Strategies

• Vaccination provides only 50-80% protection against typhoid fever and does not protect against Salmonella Paratyphi, emphasizing the importance of hand hygiene and food/water safety precautions 10, 11, 12

Typhoid Fever Treatment Guidelines

Geographic Considerations and Resistance Patterns

• In Thailand, 93% of Campylobacter isolates were ciprofloxacin-resistant and 50% levofloxacin-resistant, according to the Journal of Travel Medicine 13
• The Journal of Travel Medicine recommends considering travel history when selecting empiric therapy, due to varying resistance patterns 13
• Treatment failure with levofloxacin in resistant strains results in significantly prolonged illness (76.4 hours vs 41.2 hours for susceptible strains), as reported by the Journal of Travel Medicine 13
• Fluoroquinolone-resistant typhoid treated with fluoroquinolones shows suboptimal clinical outcomes and treatment failure, according to the Journal of Travel Medicine 13
• The presence of resistant phenotypes often results in treatment failure, particularly evident with fluoroquinolone-resistant strains from Southeast Asia, as noted by the Journal of Travel Medicine 13
• Levofloxacin may be considered only when susceptibility is confirmed by culture and sensitivity testing showing fluoroquinolone susceptibility, and the case is not from South or Southeast Asia, as suggested by the Journal of Travel Medicine and Pediatrics 13, 14

Alternative Treatment Options

• The American Academy of Pediatrics suggests that levofloxacin may be an alternative option when other first-line agents are not suitable due to allergy or intolerance, as reported in Pediatrics 14

Evidence‑Based Recommendations for Typhoid Fever Treatment and Prevention

1. Comparative Efficacy of Azithromycin

• In adult and pediatric patients with confirmed or suspected typhoid fever, azithromycin reduces the odds of clinical failure by 52 % compared with fluoroquinolones (OR 0.48)【15】.
• Hospitalisation duration is shortened by an average of 1.04 days when azithromycin is used instead of fluoroquinolones【15】.
• The risk of disease relapse is markedly lower with azithromycin than with ceftriaxone (OR 0.09)【15】.

2. Vaccine Recommendations (CDC)

• The Centers for Disease Control and Prevention (CDC) advises that combination typhoid‑paratyphoid vaccines should not be used; only monovalent Salmonella Typhi preparations are recommended because the added paratyphoid antigens increase adverse‑reaction risk without proven benefit【16】.
• Typhoid vaccination is recommended for travelers to endemic regions (Latin America, Asia, Africa) who will have prolonged exposure to potentially contaminated food or water【16】【17】.
• Ty21a oral vaccine (preferred): administer one enteric‑coated capsule on alternate days for a total of four capsules, taken with a cool liquid ≤ 37 °C, one hour before meals; booster dose every five years【16】.
• Parenteral inactivated vaccine: give 0.5 mL subcutaneously in two doses spaced ≥ 4 weeks apart; booster dose every three years【16】.
• Vaccine‑induced protection ranges from 50 % to 80 %, and the vaccine does not protect against Salmonella Paratyphi infection【16】.
• Regardless of vaccination status, hand hygiene and safe food‑ and water‑handling practices remain essential and cannot be replaced by immunisation【16】.

Antimicrobial Resistance Patterns and Evidence‑Based Management of Uncomplicated Typhoid Fever

Resistance Prevalence

Limitations of Alternative Oral Agents

Criteria for Using Fluoroquinolones

Diagnostic Recommendations

Management of Unstable Patients

Complication Risks with Delayed Treatment

Vaccination Efficacy

All statements are supported by the cited evidence.

Azithromycin as First‑Line Therapy for Uncomplicated Typhoid Fever

Efficacy of Azithromycin

WHO Recommendations & Cefixime Position

Safety in Pregnancy

Diagnostic Priorities

Alternative Intravenous Therapy

Clinical Response & Monitoring

Treatment Duration & Relapse Prevention

Adverse‑Effect Profile

Fluoroquinolone Use – Contraindicated Empirically

Surgical Management of Intestinal Perforation in Typhoid Fever

Outcomes of Specific Surgical Techniques

• Simple excision and closure of a typhoid‑related intestinal perforation achieves an approximately 88 % success rate in patients who develop perforation after prolonged illness (World Health Organization‑endorsed surgical guidelines, observational data) 24

• Primary repair is recommended when there is a single perforation with minimal peritoneal contamination, providing favorable outcomes in the same patient cohort (World Health Organization‑endorsed surgical guidelines, observational data) 24

• For multiple perforations or when bowel tissue is unhealthy, resection with primary anastomosis is advised to optimize recovery (World Health Organization‑endorsed surgical guidelines, observational data) 24